What is the difference between compound BLT and OTC lidocaine?

OTC lidocaine products are capped by FDA monograph at 4% Lidocaine as a single anesthetic agent (some Rx-strength versions reach 5%). Compound BLT contains three anesthetic agents — Benzocaine 20%, Lidocaine 10%, and Tetracaine 10% — for a total active concentration of approximately 40%, ten times the active load of OTC. BLT typically also includes Phenylephrine 0.5% as a vasoconstrictor; OTC products do not. Clinical differences: onset (15 min vs 30-45 min), depth (papillary + reticular dermis vs primarily epidermis), and duration (2-4 hr vs 1-2 hr).

Why can't OTC numbing cream just be made stronger?

FDA monographs restrict OTC topical anesthetic concentrations because higher-strength products require clinical judgment to apply safely. The maximum safe single-use dose, occlusion practices, removal protocols, and patient screening all depend on provider knowledge that consumers cannot reliably perform. The 4% Lidocaine OTC cap balances accessibility with safety — adequate for IV access, minor surface biopsies, and small areas, but insufficient for the procedures aesthetic and dermatologic practices need to perform. Compound BLT exists because licensed providers can manage the higher-concentration safety profile.

Is compound BLT safer than OTC lidocaine?

Neither is inherently 'safer' — the safety profile depends on use. OTC lidocaine has a wider safety margin because the lower concentration produces less systemic absorption under typical use. Compound BLT is safe when applied within the maximum dose (30 g on intact skin without occlusion for a healthy adult), when residual cream is removed before procedures that breach the skin, and when patients are screened for allergies. Most adverse events with BLT result from misapplication — exceeding the dose, applying over too large an area, or leaving residual cream during microneedling or laser. With proper protocol, BLT is safe and clinically superior for the procedures it is indicated for.

Why is bleeding reduction important?

The Phenylephrine vasoconstrictor in compound BLT narrows cutaneous blood vessels at the application site, reducing bleeding and bruising during injection-based procedures. For dermal fillers, Botox, microneedling, and biopsies, this means cleaner visibility during the procedure, less downtime for the patient, and reduced post-procedure swelling. OTC lidocaine products contain no vasoconstrictor, so this benefit is unique to compound formulations. For aesthetic practices serving patients who care about minimal-downtime appearance, bleeding reduction is a significant clinical advantage.

CLINICAL COMPARISON

BLT VS OTC LIDOCAINE

Q: Does OTC lidocaine work for tattoos?

OTC lidocaine provides marginal relief for tattooing. Most tattoo needles deposit ink 1-2 mm into the dermis, beneath the depth that 4% OTC lidocaine reliably reaches. Patients describe OTC numbing for tattoos as 'taking the edge off' rather than producing real anesthesia. Compound BLT reaches the dermal layer where the work happens, providing genuine pain blockade. The clinical difference is significant for long sessions and large pieces. OTC may be acceptable for very small, brief tattoo sessions where some patients will tolerate without help.

Q: Does OTC lidocaine work for microneedling?

OTC lidocaine is generally inadequate for medical microneedling and RF microneedling. The 0.5-2.5 mm needle depths used in collagen induction therapy exceed what 4% OTC numbing can reach. Patients receiving OTC-numbed microneedling commonly describe the experience as significantly painful, especially in the second half of a session as the OTC effect fades. Compound BLT is the clinical standard for medical microneedling and the only viable topical for RF microneedling (Morpheus8, Vivace, Genius). For cosmetic dermarolling at 0.25-0.5 mm, OTC may be marginally acceptable.

Q: Can patients buy compound BLT themselves?

No. Compound BLT is restricted to NPI-verified licensed healthcare and aesthetic providers. The high concentration requires clinical judgment that consumers cannot reliably perform. MediCaine verifies every order against the National Provider Identifier registry before shipping. Patients seeking high-strength topical anesthesia for medical procedures should ask their provider to use compound BLT during the procedure rather than attempting to source it themselves.

Q: What about LMX 4 and other OTC numbing creams?

LMX 4 (Lidocaine 4%) is the most common OTC dedicated tattoo and procedure numbing product. LMX 5 (Lidocaine 5%) is a slightly higher prescription-strength version. Other OTC brands include Numbify, Hush, Ebanel, Dr. Numb, Uber Numb — all single-agent Lidocaine in the 4-5% range with similar pharmacokinetic profiles. None reach the depth or duration of compound BLT. For licensed providers, compound BLT is the clinical standard; for OTC retail or non-medical settings, LMX-class products are the appropriate alternative.

Why over-the-counter 4-5% lidocaine cannot deliver compound-grade results — and the specific situations where OTC remains the appropriate choice.

SIDE BY SIDE

TEN-FOLD CONCENTRATION GAP

METRIC	COMPOUND BLT	OTC LIDOCAINE (LMX-class)
Active agents	3 — Benzocaine, Lidocaine, Tetracaine (+ Phenylephrine)	1 — Lidocaine
Total active concentration	~ 40%	~ 4-5%
Onset	~ 15 min	30 – 45 min
Depth	Reticular dermis	Primarily epidermis
Duration	2 – 4 hr (Ultra: 3-5)	1 – 2 hr
Vasoconstrictor	Yes (Phenylephrine)	No
Bleeding reduction	Yes	No
Regulatory status	503A compounded — NPI-verified providers only	OTC retail
Typical retail consumer use	Not applicable	Common
Best for	Aesthetic, dermatologic, microneedling, laser, tattoo	IV access, minor surface biopsy, retail consumer self-care

WHY THE GAP MATTERS

WHERE OTC FALLS SHORT

Depth — the dermis isn't optional

Most aesthetic procedures — fillers, microneedling, RF microneedling, laser — generate pain in the dermal layer, 1-2 mm beneath the surface. OTC 4% lidocaine reliably reaches the upper epidermis and tapers off well before the reticular dermis. Patients receiving OTC-numbed dermal procedures describe the experience as "taking the edge off" rather than producing genuine anesthesia. Compound BLT's three-agent formulation specifically targets the dermal layer because that's where the work happens.

Duration — the second half of every session

A 4% OTC lidocaine product provides 60-90 minutes of partial anesthesia. Lip filler appointments are 30 minutes — OTC covers them. Microneedling and laser hair removal sessions run 60-90 minutes — OTC fades exactly when the patient needs it most. Multi-area treatments (face plus neck plus decolletage) need 2-3 hours of coverage that OTC cannot provide. Compound BLT's 2-5 hour duration window matches the actual length of clinical procedures.

Bleeding — the cosmetic dimension

The Phenylephrine vasoconstrictor in compound BLT reduces capillary leak at injection points. Filler patients experience less bruising, less swelling, and less downtime. Microneedling patients see less weeping during the procedure, which improves the practitioner's visibility and the final result. OTC lidocaine contains no vasoconstrictor, so this entire cosmetic dimension is missing. For aesthetic practices serving patients who care about minimal-downtime appearance, this difference shows up directly in reviews and retention.

Workflow — onset compounds across the day

OTC lidocaine requires 30-45 minutes of pre-procedure wait time. Compound BLT requires 15-25 minutes. Across a busy day with 8-12 procedures, the 15-minute difference per appointment adds up to 2-3 hours of saved chair time — equivalent to 2-3 additional procedures per day per chair. For a multi-provider practice, this is a measurable revenue advantage that funds the cost difference many times over.

WHEN OTC WINS

DON'T USE BLT FOR EVERYTHING

Compound BLT is overkill — and sometimes inappropriate — for certain situations. Use the right tool.

USE OTC WHEN

•Patient is self-administering at home for an OTC-labeled use
•IV access or simple venipuncture
•Very small, very superficial body area
•Short, brief procedure (under 30 minutes)
•Setting without NPI-verified prescribing access
•Patient with documented allergy to all ester anesthetics
•Retail / consumer self-care use

USE COMPOUND BLT WHEN

✓Aesthetic procedures — fillers, Botox, lip augmentation
✓Microneedling and RF microneedling
✓Laser hair removal, tattoo removal, fractional resurfacing
✓Dermatologic biopsies, Mohs surgery
✓Professional tattoo and paramedical tattooing
✓Procedures longer than 90 minutes
✓Multi-area treatments
✓Workflows where bleeding reduction matters

Read the BLT Guide

FAQ

BLT VS OTC QUESTIONS

What's the difference between BLT and OTC lidocaine?+

OTC is capped at 4% Lidocaine as a single agent. Compound BLT is Benzocaine 20% + Lidocaine 10% + Tetracaine 10% — ~40% total, ten times the active load. BLT typically includes Phenylephrine 0.5% as a vasoconstrictor; OTC does not. Clinical differences: onset (15 min vs 30-45 min), depth (reticular dermis vs epidermis), and duration (2-4 hr vs 1-2 hr).

Why can't OTC just be made stronger?+

FDA monographs cap OTC concentrations because higher strengths require clinical judgment to apply safely. Maximum dose, occlusion practices, removal protocols, and patient screening all depend on provider knowledge consumers cannot perform reliably. Compound BLT exists because licensed providers can manage the higher-concentration safety profile.

Does OTC lidocaine work for tattoos?+

OTC provides marginal relief. Tattoo needles deposit ink 1-2 mm into the dermis, beneath what 4% OTC reliably reaches. Patients describe OTC numbing as "taking the edge off" rather than genuine anesthesia. Compound BLT reaches the dermal layer where the work happens. See the tattoo guide.

Does OTC lidocaine work for microneedling?+

Generally inadequate. 0.5-2.5 mm needle depths exceed what OTC reaches. Patients report significant pain in the second half of a session as OTC fades. Compound BLT is the clinical standard for medical microneedling and the only viable topical for RF microneedling. For cosmetic dermarolling at 0.25-0.5 mm, OTC may be marginally acceptable.

Is BLT safer than OTC?+

Neither is inherently safer — depends on use. OTC has a wider safety margin from lower concentration. BLT is safe within max dose (30 g on intact skin without occlusion, healthy adult), when residual is removed before procedures breach skin, and with allergy screening. Most adverse events with BLT come from misapplication.

Can patients buy compound BLT themselves?+

No. Compound BLT is restricted to NPI-verified licensed providers. The high concentration requires clinical judgment consumers cannot reliably perform. Patients seeking high-strength topical anesthesia for medical procedures should ask their provider to use compound BLT during the procedure.

What about LMX, Numbify, Hush, Ebanel?+

All single-agent Lidocaine in the 4-5% range with similar pharmacokinetic profiles. None reach the depth or duration of compound BLT. For licensed providers, compound BLT is the clinical standard; for OTC retail or non-medical settings, LMX-class products are the appropriate alternative.

Why does bleeding reduction matter?+

Phenylephrine narrows cutaneous blood vessels, reducing bleeding and bruising during injection procedures. Less downtime for filler patients, cleaner visibility for microneedling, reduced post-procedure swelling. OTC contains no vasoconstrictor, so this benefit is unique to compound formulations. For aesthetic practices, it shows up in reviews and retention.

UPGRADE FROM OTC

If you have NPI verification, OTC lidocaine is leaving clinical results on the table. Compound BLT is the standard for procedures that breach the dermis.

Build Your Order Call (310) 889-0733